SELLAS Life Sciences receives additional $16.1M from warrant exercises, total $42.6M since Dec 31

SELLAS Life Sciences Group, Inc.

Additional $16.1M in proceeds from warrant exercises since January 8, 2026.
Total warrant exercise proceeds since Dec 31, 2025: approximately $42.6M.
Shares outstanding as of March 11, 2026: 179,536,724.
Previously reported $26.5M in proceeds as of January 8, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.